NCT03444519View on ClinicalTrials.gov

The Therapeutic Time Window of Mannitol During Craniotomy for Optimal Brain Relaxation in Patients With Supratentorial Tumours

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 14, 2019

Study Completion Date

April 1, 2019

Conditions
Supratentorial Tumors
Interventions
DRUG

Mannitol

This drug is in our routine use of neuroanesthesia, are given for facilitate brain relaxation

Trial Locations (1)

021

Fudan University affiliated Huashan Hospital, Shanghai

All Listed Sponsors
lead

Huashan Hospital

OTHER

NCT03444519 - The Therapeutic Time Window of Mannitol During Craniotomy for Optimal Brain Relaxation in Patients With Supratentorial Tumours | Biotech Hunter | Biotech Hunter